ESC Premium Access

DOACs to prevent VTE and to reduce the risk of stroke during hospitalization and during the first several months after hospital discharge.

Topic: Antiarrhythmic drugs
Organised by Medscape Education, supported with an educational grant by Portola

Presentation

About the speaker

Mr Mike Gibson

Boston (United States of America)
1 presentation
0 follower

5 more presentations in this session

Welcome and introductions - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Speaker: Doctor S. Goldhaber (Boston, US)

Thumbnail

The critical unmet need of VTE prophylaxis in medically ill patients.

Speaker: Doctor S. Goldhaber (Boston, US)

Thumbnail

Antidotes for direct oral anticoagulants (DOACs).

Speaker: Doctor A. Cohen (London, GB)

Thumbnail

Case discussion - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Thumbnail

Summary and concluding remarks - New DOACs to prevent PE and stroke in HF and other hospitalized patients.

Speaker: Doctor S. Goldhaber (Boston, US)

Thumbnail

Access the full session

New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients

Speakers: Mr M. Gibson, Doctor S. Goldhaber, Doctor S. Goldhaber, Doctor A. Cohen, Doctor S. Goldhaber
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk